Denmark-based clinical-stage biopharmaceutical company
Breye Therapeutics has raised €4.0M across 1 funding round from 2 investors, most recently a Seed round in Nov 2022. Based in Copenhagen, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-11 | Seed | €4.0M |
| Novo Holdings,Sound Bioventures |
| View deal → |
